Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida

Company Overview - Alvotech is a global biotech company focused on the development and manufacture of biosimilar medicines for patients worldwide [3] - The company aims to be a leader in the biosimilar space by delivering high-quality, cost-effective products and services through a fully integrated approach and broad in-house capabilities [3] - Alvotech has launched two biosimilars and has a development pipeline that includes nine disclosed biosimilar candidates targeting various diseases such as autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer [3] Strategic Partnerships - Alvotech has formed a network of strategic commercial partnerships to enhance its global reach and leverage local expertise in multiple markets, including the United States, Europe, Japan, China, and parts of South America, Africa, and the Middle East [3] - Notable commercial partners include Teva Pharmaceuticals, STADA Arzneimittel AG, Fuji Pharma Co., Ltd, and several others across various regions [3] Upcoming Events - Alvotech will participate in Barclays 27th Annual Global Healthcare Conference in Miami, Florida, from March 11-13, 2025, with CEO Robert Wessman and the management team hosting one-on-one meetings [1] - A fireside chat is scheduled for March 12, 2025, at 9:30-9:55 am EDT, which will be accessible via an audio webcast for investors and the general public [2]